Letter: tofacitinib in biologic-experienced ulcerative colitis-a single-centre real-world experience in Australia

MLA

Lo, Sw, et al. Letter: Tofacitinib in Biologic-Experienced Ulcerative Colitis-a Single-Centre Real-World Experience in Australia. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1315690097&authtype=sso&custid=ns315887.

APA

Lo, S., Connell, W., Kamm, M., Lust, M., & Wright, E. (2021). Letter: tofacitinib in biologic-experienced ulcerative colitis-a single-centre real-world experience in Australia.

Chicago

Lo, Sw, W Connell, Ma Kamm, M Lust, and Ek Wright. 2021. “Letter: Tofacitinib in Biologic-Experienced Ulcerative Colitis-a Single-Centre Real-World Experience in Australia.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1315690097&authtype=sso&custid=ns315887.